Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1940 1
1965 1
1976 1
1982 1
1983 2
1984 1
1985 1
1987 4
1988 2
1989 6
1990 3
1991 4
1992 8
1993 14
1994 7
1995 7
1996 13
1997 12
1998 7
1999 8
2000 7
2001 6
2002 9
2003 27
2004 10
2005 12
2006 17
2007 11
2008 4
2009 13
2010 21
2011 20
2012 11
2013 15
2014 10
2015 11
2016 14
2017 10
2018 9
2019 13
2020 11
2021 14
2022 14
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 8837544

372 results

Results by year

Filters applied: . Clear all
Page 1
Osteoporosis.
Gopinath V. Gopinath V. Med Clin North Am. 2023 Mar;107(2):213-225. doi: 10.1016/j.mcna.2022.10.013. Epub 2023 Jan 5. Med Clin North Am. 2023. PMID: 36759092 Review.
Correction: Novel formulations of oral bisphosphonates in the treatment of osteoporosis.
Fuggle N, Al-Daghri N, Bock O, Branco J, Bruyère O, Casado E, Cavalier E, Cortet B, de Wit M, Giusti A, Halbout P, Harvey NC, Hiligsmann M, Kaufman JM, Kurth A, Maggi S, Matijevic R, Minisola S, Palacios S, Radermecker RP, Thomasius F, Tuzun S, Veronese N, Kanis JA, Reginster JY, Rizzoli R, Cooper C. Fuggle N, et al. Aging Clin Exp Res. 2023 Jun;35(6):1375-1376. doi: 10.1007/s40520-022-02319-1. Aging Clin Exp Res. 2023. PMID: 36595210 Free PMC article. No abstract available.
Ocular Side Effects of Bisphosphonates: A Review of Literature.
Chartrand NA, Lau CK, Parsons MT, Handlon JJ, Ronquillo YC, Hoopes PC, Moshirfar M. Chartrand NA, et al. J Ocul Pharmacol Ther. 2023 Jan-Feb;39(1):3-16. doi: 10.1089/jop.2022.0094. Epub 2022 Nov 21. J Ocul Pharmacol Ther. 2023. PMID: 36409537 Review.
Treating osteoporosis: risks and management.
Zhu J, March L. Zhu J, et al. Aust Prescr. 2022 Oct;45(5):150-157. doi: 10.18773/austprescr.2022.054. Epub 2022 Oct 4. Aust Prescr. 2022. PMID: 36382174 Free PMC article. Review.
Novel formulations of oral bisphosphonates in the treatment of osteoporosis.
Fuggle N, Al-Daghri N, Bock O, Branco J, Bruyère O, Casado E, Cavalier E, Cortet B, de Wit M, Giusti A, Halbout P, Harvey NC, Hiligsmann M, Kaufman JM, Kurth A, Maggi S, Matijevic R, Minisola S, Palacios S, Radermecker RP, Thomasius F, Tuzun S, Veronese N, Kanis JA, Reginster JY, Rizzoli R, Cooper C. Fuggle N, et al. Aging Clin Exp Res. 2022 Nov;34(11):2625-2634. doi: 10.1007/s40520-022-02272-z. Epub 2022 Nov 4. Aging Clin Exp Res. 2022. PMID: 36331798 Free PMC article. Review.
372 results